HSK47388
/ Haisco
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 06, 2026
A Study for HSK47388 in Participants With Ulcerative Colitis
(clinicaltrials.gov)
- P2 | N=150 | Recruiting | Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
January 13, 2026
A Study for HSK47388 in Participants With Ulcerative Colitis
(clinicaltrials.gov)
- P2 | N=150 | Not yet recruiting | Sponsor: Haisco Pharmaceutical Group Co., Ltd.
New P2 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
September 26, 2025
Food Effect Study of HSK47388 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=15 | Completed | Sponsor: Haisco Pharmaceutical Group Co., Ltd.
New P1 trial
September 06, 2025
A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=220 | Not yet recruiting | Sponsor: Haisco Pharmaceutical Group Co., Ltd.
New P2 trial • Dermatology • Immunology • Psoriasis
1 to 4
Of
4
Go to page
1